Whole Exome Sequencing Reveals Multiple Driver Events in Chronic Lymphocytic Leukemia Patients with Acquired Ibrutinib Resistance

被引：0
|
作者：
Underbayev, Chingiz [1 ]
Ahn, Inhye E. [1 ]
Harris, Hailey [1 ]
Vaughn, Lauren T. [1 ]
Pirooznia, Mehdi [2 ]
Xi, Liqiang [3 ]
Raffeld, Mark [3 ]
Herman, Sarah E. M. [1 ]
Wiestner, Adrian [1 ]
机构：
[1] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
[2] NHLBI, Bioinformat & Computat Biol Core, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA
[3] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127364
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Whole-genome sequencing reveals cellular origin of concomitant chronic lymphocytic leukemia and multiple myeloma: a case report
    Zhang, Jianing
    Ma, Ji
    Li, Ying
    Lv, Xiao
    Feng, Lili
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [22] Combination of ibrutinib with immunochemotherapy in patients with chronic lymphocytic leukemia
    Tomowiak, Cecile
    Leleu, Xavier
    HEMATOLOGIE, 2015, 21 (04): : 206 - 207
  • [23] Combined Ibrutinib and Venetoclax for Patients With Chronic Lymphocytic Leukemia
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 16 - 17
  • [24] A Multicenter Study of Ibrutinib Resistance Development and Intervention with Venetoclax in Patients with Chronic Lymphocytic Leukemia
    Rogers, Kerry A.
    Wei, Lai
    Bhat, Seema A.
    Jones, Dan
    Seymour, Erlene K.
    Stephens, Deborah M.
    Christine, J.
    Byrd, John C.
    Woyach, Jennifer
    BLOOD, 2019, 134
  • [25] Nurse-like cells mediate ibrutinib resistance in chronic lymphocytic leukemia patients
    Boissard, F.
    Fournie, J-J
    Quillet-Mary, A.
    Ysebaert, L.
    Poupot, M.
    BLOOD CANCER JOURNAL, 2015, 5 : e355 - e355
  • [26] Nurse-like cells mediate ibrutinib resistance in chronic lymphocytic leukemia patients
    F Boissard
    J-J Fournié
    A Quillet-Mary
    L Ysebaert
    M Poupot
    Blood Cancer Journal, 2015, 5 : e355 - e355
  • [27] Analysis of clonal evolution in cancer using whole exome sequence data reveals that subclonal driver mutations predict poor prognosis in chronic lymphocytic leukemia
    Carter, Scott L.
    Landau, Dan-Avi
    Stojanov, Petar
    McKenna, Aaron
    Cibulskis, Kristian
    Lawrence, Michael S.
    Lohr, Jens
    Stevenson, Kristen
    Neuberg, Donna
    Meyerson, Matthew
    Wu, Catherine J.
    Getz, Gad
    CANCER RESEARCH, 2013, 73 (08)
  • [28] Incidence and risk factors of bleedingrelated adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib
    Wiestner, Adrian
    Lipsky, Andrew
    Farooqui, Mohammed
    Tian, Xin
    Cullinane, Ann
    Nghiem, Khanh
    Lozier, Jay
    LEUKEMIA & LYMPHOMA, 2015, 56 : 163 - 164
  • [29] Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia
    Khountham, Soun
    Shindiapina, Polina
    Mo, Xiaokui
    Lachowiez, Curtis
    Wiczer, Tracy
    Mousa, Luay
    Rogers, Kerry A.
    Andritsos, Leslie A.
    Woyach, Jennifer A.
    Byrd, John C.
    Spurgeon, Stephen E.
    Awan, Farrukh T.
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 716 - 721
  • [30] WHOLE EXOME SEQUENCING OF 278 CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS FROM THE CLL8 TRIAL UNCOVERS DRIVER MUTATIONS WITH CLINICAL IMPACT AND THEIR EVOLUTIONARY HISTORY IN CANCER PATHOGENESIS
    Tausch, E.
    Landau, D.
    Taylor-Weiner, A.
    Stewart, C.
    Reiter, J.
    Bahlo, J.
    Kluth, S.
    Bozic, I.
    Lawrence, M.
    Boettcher, S.
    Cibulskis, K.
    Mertens, D.
    Sougnez, C.
    Rosenberg, M.
    Hess, J.
    Carter, S.
    Edelmann, J.
    Kless, S.
    Fink, A.
    Fischer, K.
    Ritgen, M.
    Kneba, M.
    Gabriel, S.
    Lander, E.
    Nowak, M.
    Doehner, H.
    Hallek, M.
    Neuberg, D.
    Getz, G.
    Stilgenbauer, S.
    Wu, C.
    HAEMATOLOGICA, 2015, 100 : 335 - 336
12345